Unimedic Pharma is a fully integrated Swedish specialty pharma company with broad experience in drug development, distribution, and marketing of pharmaceuticals. Our core purpose is to contribute to better health. By developing niche pharmaceuticals for children and adults with special medical needs in close collaboration with the healthcare sector, we strive to reach our mission. Unimedic Pharma supply the Nordic region and northern Europe with a wide range of pharmaceuticals in several therapeutic areas. The business is divided into three main areas: specialty pharmaceuticals (licensed), unlicensed pharmaceuticals and contract development and manufacturing organisation (CDMO). An important part of our daily work is to continuously add new pharmaceutical to our product portfolio through drug development, acquisitions, and long-term strategic partnerships. Offering a wide range of pharmaceuticals strengthens our ambition to contribute to better health. The company’s head office is located in Solna, Sweden. We operate primarily in the Nordic region and northern Europe. Unimedic Pharma is a wholly owned subsidiary of MedCap AB (publ), listed on Nasdaq Stockholm Mid Cap.
